AFA
CLMT icon

Alta Fundamental Advisers’s Calumet Specialty Products CLMT Stock Holding History

Alta Fundamental Advisers’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-459,937
Closed -$7.25M – 29
2025
Q2 		$7.25M Hold
459,937
– – 3.71% 11
2025
Q1 		$5.83M Sell
459,937
-117,284
-20% -$1.84M 3.75% 10
2024
Q4 		$12.7M Hold
577,221
– – 3.8% 11
2024
Q3 		$10.3M Buy
577,221
+501,934
+667% +$8.04M 2.96% 12
2024
Q2 		$1.21M Buy
+75,287
New +$1.19M 0.38% 25

Other funds holding CLMT

WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Alta Fundamental Advisers's CLMT Position: Q3 2025 in Review

Alta Fundamental Advisers sold out of Calumet Specialty Products (CLMT) in Q3 2025, closing a stake of 459,937 shares — an estimated $7.25M sold.

Alta Fundamental Advisers first reported a position in CLMT in Q2 2024 and held it in 5 quarters. The position peaked at $12.7M in Q4 2024. 149 funds tracked by Wall St. Rank hold CLMT as of Q3 2025.

  • Alta Fundamental Advisers reported no remaining Calumet Specialty Products position as of Q3 2025 after selling out during the quarter.
  • Alta Fundamental Advisers sold 459,937 Calumet Specialty Products shares in Q3 2025, an estimated $7.25M.
  • Alta Fundamental Advisers first reported a position in Calumet Specialty Products in Q2 2024 and held it in 5 quarters.
  • Alta Fundamental Advisers's Calumet Specialty Products position peaked at $12.7M in Q4 2024.
  • 149 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2025.

Based on Alta Fundamental Advisers's 13F filing for Q3 2025, filed 13 Nov 2025.